RNAi
At the Association for Molecular Pathology annual meeting, cancer researcher William Hahn talked about efforts to map cancer fitness genes at the genome scale.
Tropic Biosciences, BASF Partner to Use Gene Editing Tech for Crop Development
Tropic Bio will use its GEiGS (Gene Editing induced Gene Silencing) platform to develop desirable agricultural traits in BASF's strategic crop varieties.
GreenLight Biosciences Raises $50M in Private Financing Round
GreenLight Biosciences is using a proprietary cell-free RNA production technology to develop RNA-based products for the agricultural market.
Cowen Initiates Coverage of Horizon Discovery at Outperform
The investment bank began coverage with an Outperform rating, noting that Horizon's recent acquisition of Dharmacon is highly complementary and synergistic.
Cancer Dependency Maps Developed by Two Research Teams
Researchers from the Broad Institute and Novartis used RNA interference to generate catalogs of genes that cancer cells rely on to grow and survive.